{"data":{"type":"feed_item_ai","id":407246,"entity_id":"wefunder:feed_item:407246","attributes":{"canonical_url":"https://wefunder.com/feed/407246","retrieval_urls":{"canonical":"https://wefunder.com/feed/407246","json":"https://wefunder.com/feed/407246.json","markdown":"https://wefunder.com/feed/407246.md","ai_json":"https://wefunder.com/feed/407246.ai.json","ai_text":"https://wefunder.com/feed/407246.ai.txt","changelog_json":"https://wefunder.com/feed/407246.changelog.json","schema":"https://wefunder.com/.well-known/ai-profile-schema.json"},"updated_at":"2026-10-15T01:33:50.289Z","generated_at":"2026-10-24T12:15:56Z","feed_item":{"id":407246,"entity_id":"wefunder:feed_item:407246","type":"FeedItem::Update","title":"In Good Company: Watch the Replay + Why Our Next Clinical Trial Matters | Sen-Jam Pharmaceutical","content_plain":"Dear Sen-Jam Community, Great science takes great partners. And last Thursday, we had the pleasure of bringing two of ours together for our latest In Good Company webinar. Joining CEO Jim Iversen were Johann de Bruyn of TASK Clinical and Kiran Vep...","published_at":"2026-10-12T15:50:53.768Z","updated_at":"2026-10-15T01:33:50.289Z","canonical_url":"https://wefunder.com/feed/407246","author":{"name":"Christine Leonard","profile_url":"https://wefunder.com/christineleonard"},"subject":{"name":"Sen-Jam Pharmaceutical","profile_url":"https://wefunder.com/senjam"}},"key_claims":[{"claim_id":"claim-feed-item-title","text":"Title: In Good Company: Watch the Replay + Why Our Next Clinical Trial Matters | Sen-Jam Pharmaceutical","citation":"https://wefunder.com/feed/407246#claim-feed-item-title","observed_at":"2026-10-15T01:33:50Z","expires_at":"2026-10-22T01:33:50Z"},{"claim_id":"claim-feed-item-published-at","text":"Published at: 2026-10-12 15:50:53 UTC","citation":"https://wefunder.com/feed/407246#claim-feed-item-published-at","observed_at":"2026-10-15T01:33:50Z","expires_at":"2026-10-22T01:33:50Z"}],"verified_facts":[{"claim_id":"claim-feed-item-title","text":"Title: In Good Company: Watch the Replay + Why Our Next Clinical Trial Matters | Sen-Jam Pharmaceutical","citation":"https://wefunder.com/feed/407246#claim-feed-item-title","observed_at":"2026-10-15T01:33:50Z","expires_at":"2026-10-22T01:33:50Z"},{"claim_id":"claim-feed-item-published-at","text":"Published at: 2026-10-12 15:50:53 UTC","citation":"https://wefunder.com/feed/407246#claim-feed-item-published-at","observed_at":"2026-10-15T01:33:50Z","expires_at":"2026-10-22T01:33:50Z"}],"feed_item_claims":{"title":"In Good Company: Watch the Replay + Why Our Next Clinical Trial Matters | Sen-Jam Pharmaceutical","content_plain":"Dear Sen-Jam Community, Great science takes great partners. And last Thursday, we had the pleasure of bringing two of ours together for our latest In Good Company webinar. Joining CEO Jim Iversen were Johann de Bruyn of TASK Clinical and Kiran Vep..."},"computed_metrics":{"likes":4,"comments":1,"reposts":0},"relationships":[{"source_entity_id":"wefunder:feed_item:407246","relation":"authored_by","target_url":"https://wefunder.com/christineleonard"},{"source_entity_id":"wefunder:feed_item:407246","relation":"posted_to","target_url":"https://wefunder.com/senjam"}],"provenance":{"source":"wefunder_public_feed_item","last_verified_at":"2026-10-15T01:33:50Z","claims":{"title":{"source":"feed_item.title","last_verified_at":"2026-10-15T01:33:50Z","as_of":"2026-10-15T01:33:50Z","confidence":"high"},"published_at":{"source":"feed_item.published_at","last_verified_at":"2026-10-15T01:33:50Z","as_of":"2026-10-12T15:50:53Z","confidence":"high"}}}}}}